RESEARCH & SCIENTIFIC OVERVIEW
Peptide Research Australia — Molecular Biology & Reference Science
Pure Recovery Labs provides peer-reviewed analytical data, CAS specifications, sequence alignments, and preclinical scientific references for peptide research in Australia. All reference compounds are synthesized exclusively for in-vitro laboratory evaluation and receptor binding assays.
OUR ANALYTICAL APPROACH
Precision-Sourced. Independently Verified.
Every compound in our catalog undergoes independent third-party High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (LC-MS) testing by Janoshik Analytical prior to release.
Our sourcing standards require quality-focused manufacturing and traceable batch documentation. We supply peptide compounds exclusively for research purposes, and our product descriptions reference published preclinical literature only (no therapeutic claims are made).
COMPOUND REFERENCE
Peptide Classification & Analytical Data Table
| Compound | Class | Sequence / Composition | MW (DA) | Primary Research Area | SKU / Janoshik COA Key |
|---|---|---|---|---|---|
| BPC-157 10mg | Pentadecapeptide | GEPPPGKPADDAGLV | 1419.56 | Tissue Biology, GI Research, Inflammatory Pathways | PRL-BPC157-10MG | COA: VXXPES78PYD3 |
| TB-500 10mg | Thymosin β4 Fragment | Ac-LKKTETQ | 888.0 | Tissue Biology, Cell Migration, Angiogenesis | PRL-TB500-10MG | HPLC Verified |
| GHK-Cu 50mg | Copper Tripeptide | Gly-His-Lys · Cu²⁺ | 340.38 | ECM Biology, Collagen Research, Skin Biology | PRL-GHKCU-50MG | COA: F8MIBZFZW3YP |
| GHK-Cu 100mg | Copper Tripeptide | Gly-His-Lys · Cu²⁺ | 340.38 | ECM Biology, Dermal Remodeling Research | PRL-GHKCU-100MG | COA: 9Q35X2A585SET |
| Retatrutide 10mg | Triple Agonist Peptide | Modified glucagon/GIP/GLP-1 receptor agonist | ~4731 | Metabolic Research | PRL-RETATRUTIDE-10MG | HPLC Verified |
| AOD-9604 10mg | HGH Fragment | hGH Fragment 176–191 | 1815.1 | Metabolic & Lipid Research | PRL-AOD9604-10MG | HPLC Verified |
| Tesamorelin 10mg | GHRH Analogue | Modified GHRH(1–44) | ~5135 | Peptide & Growth Research | PRL-TESAMORELIN-10MG | HPLC Verified |
| CJC-1295 + Ipamorelin 5/5mg | Peptide Combination | CJC-1295 + Ipamorelin | Varies | Growth Hormone Research | PRL-CJC1295IPAMORELIN-5MG5MG | COA: KPSQDAP7FBG1 |
| CJC-1295 DAC 5mg | GHRH Analogue + DAC | Tetrasubstituted 30-amino acid peptide | 3647.28 | Pulsatile GH Signaling Research | PRL-CJC1295DAC-5MG | COA: MDNSSVV6SH3W |
| Ipamorelin 10mg | GH Secretagogue | Aib-His-D-2Nal-D-Phe-Lys-NH2 | 711.86 | Ghrelin Receptor Signaling | PRL-IPAMORELIN-10MG | COA: 7YE6S1T3TLAS |
| MOTS-c 10mg | Mitochondrial Peptide | MRWQEMGYIFYPRKLR | 2174.6 | Mitochondrial Biology, Cellular Energy | PRL-MOTSC-10MG | HPLC Verified |
| SS-31 50mg | Mitochondrial-Targeted Peptide | H-D-Arg-Dmt-Lys-Phe-NH₂ | ~639.8 | Mitochondrial & Cellular-Energy Research | PRL-SS31-50MG | HPLC Verified |
| NAD+ 500mg | Dinucleotide Coenzyme | C₂₁H₂₇N₇O₁₄P₂ | 663.43 | Redox Biology, Cellular Energy, Longevity Research | PRL-NAD-500MG | HPLC Verified |
| Epitalon 10mg | Tetrapeptide | Ala-Glu-Asp-Gly | 390.35 | Cellular & Longevity Research | PRL-EPITALON-10MG | COA: WMT11RTX5RXQ |
| KPV 10mg | Tripeptide | Lys-Pro-Val | 356.42 | Inflammatory & Cellular Signalling Research | PRL-KPV-10MG | HPLC Verified |
| Thymosin Alpha-1 10mg | Thymic Peptide | Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu | ~3108 | Immune & Cellular-Signalling Research | PRL-THYMOSINALPHA1-10MG | HPLC Verified |
| DSIP 10mg | Nonavalent Peptide | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu | 848.81 | Sleep & Neurobiological Research | PRL-DSIP-10MG | COA: XVSE1TEQ4XUQ |
| Glutathione 600mg | Tripeptide Antioxidant | γ-Glu-Cys-Gly | 307.32 | Antioxidant & Redox Research | PRL-GLUTATHIONE-600MG | COA: DB5BW8HBPMWD |
| Semax 10mg | Heptapeptide | Met-Glu-His-Phe-Pro-Gly-Pro | 813.9 | Neurobiological & Cognitive Research | PRL-SEMAX-10MG | HPLC Verified |
| Selank 10mg | Heptapeptide | Thr-Lys-Pro-Arg-Pro-Gly-Pro | 751.9 | Neurobiological & Signalling Research | PRL-SELANK-10MG | HPLC Verified |
| PT-141 10mg | Cyclic Heptapeptide | Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OH | ~1025 | Peptide Signalling Research | PRL-PT141-10MG | HPLC Verified |
| Kisspeptin 10mg | Decapeptide | Kisspeptin-10 sequence | ~1302 | Reproductive & Peptide-Signalling Research | PRL-KISSPEPTIN-10MG | HPLC Verified |
| Oxytocin 10mg | Nonavalent Peptide | CYIQNCPLG-NH₂ | 1007.19 | Peptide-Signalling Research | PRL-OXYTOCIN-10MG | HPLC Verified |
| HCG 5000IU | Glycoprotein Hormone | α/β glycoprotein hormone complex | ~36,700 | Reproductive & Hormonal Research | PRL-HCG-5000IU | HPLC Verified |
| Melanotan II 10mg | Cyclic Heptapeptide | Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂ | 1024.2 | Melanocortin Receptor Research | PRL-MELANOTANII-10MG | HPLC Verified |
| Bacteriostatic Water 10ml | Laboratory Supply | Sterile water + benzyl alcohol 0.9% | N/A | Laboratory Preparation / Research Supply | PRL-BACTERIOSTATICWATER-10ML | Lab Grade |
| Pinealon 10mg | Tripeptide | Glu-Asp-Arg | ~403.4 | Peptide & Cellular Research | PRL-PINEALON-10MG | HPLC Verified |
| Cagrilintide 10mg | Amylin Analogue Peptide | Modified amylin analogue | ~4100 | Metabolic Research | PRL-CAGRILINTIDE-10MG | HPLC Verified |
| AHK-Cu 100mg | Copper Tripeptide | Ala-His-Lys · Cu²⁺ | ~401 | ECM & Skin Biology Research | PRL-AHKCU-100MG | HPLC Verified |
| KLOW 80mg Stack | Proprietary Combination | BPC-157 + TB-500 + KPV + GHK-Cu | Composite | Multi-Pathway Tissue & ECM Research | PRL-KLOW-80MG | Multi-COA Tested |
| GLOW 70mg Stack | Proprietary Combination | Proprietary blend | Composite | Aesthetics & Longevity Research | PRL-GLOW-70MG | Multi-COA Tested |
| Tirzepatide 10mg | Dual Agonist Peptide | Modified GIP/GLP-1 receptor agonist | ~4813 | Metabolic & Biological Research | PRL-TIRZEPATIDE-10MG | HPLC Verified |
"The study of bioactive peptides represents one of the most dynamic frontiers in molecular biology — offering precise, receptor-targeted tools for understanding fundamental biological processes."
— Pure Recovery Labs Scientific Position StatementPRECLINICAL LITERATURE & PUBMED REFERENCES
Key Scientific Literature & Receptor Studies
BPC-157: VEGFR2 Activation & Nitric Oxide (NO) System
Preclinical literature evaluates pentadecapeptide BPC-157 in cellular models for its role in promoting vascular endothelial growth factor receptor 2 (VEGFR2) expression and stimulating localized NO synthesis during tissue repair signaling.
GHK-Cu: Gene Expression & Collagen Type I Biosynthesis
Copper tripeptide-1 research demonstrates significant gene modulation related to extracellular matrix turnover, upregulating mRNA levels for collagen type I, elastin, and glycosaminoglycans in dermal fibroblast cultures.
Retatrutide: Triple Receptor Dynamics (GLP-1 / GIP / GCGR)
Pharmacological trials assess Retatrutide as a novel tri-agonist targeting glucagon, GIP, and GLP-1 receptors simultaneously, evaluating glucagon-mediated energy expenditure alongside incretin signaling in metabolic models.
TB-500: Actin Sequestration & Cell Motility
Thymosin β4 fragment research focuses on G-actin binding mechanisms, facilitating rapid cell migration, endothelial cell differentiation, and cytoskeletal reorganization in cellular wound models.